Biomolecules interact, and the strength of these interactions (i.e., their affinity) influences their molecular and cellular functions. Although many powerful techniques exist to measure binding affinities between biomolecules, mass spectrometry is unique in its ability to read out quantitative information for hundreds or thousands of proteins simultaneously.
Matthew Makowski (photo) and Cathrin Graewe, both researchers in the group of Michiel Vermeulen (Proteomics and Chromatin Biology), in a collaborative project with members of Till Bartke’s group from the Institute of Functional Epigenetics in Munich, recently described a new assay that leverages the unbiased, proteome-wide potential of the mass spectrometer to globally profile apparent binding affinities between proteins and DNA or nucleosomes. The study, titled “Global profiling of protein-DNA and protein-nucleosome binding affinities using quantitative mass spectrometry”, was recently published in Nature Communications.Of note, Vermeulen and colleagues quantified binding between canonical DNA motifs and transcription factors, observing that canonical motifs often bind many transcription factors with a variety of different affinities. In addition, they reported a novel high affinity interaction between chromatin associated protein complexes and a G-quadruplex DNA structure. In a final example, the authors studied how histone tail modifications regulate apparent binding affinities of chromatin associated protein complexes to nucleosomes.
In future work, the authors hope to use their assay to study how combinations of DNA motifs, DNA modifications, and histone modifications affect binding affinities of protein complexes to nucleosomes. The authors are also interested in quantitatively comparing transcription factor-DNA binding affinity with transcriptional output via next-generation sequencing and single-molecule approaches.
Related news items
T cell immunity is directed by tetraspanin CD53
5 July 2022 T cells are immune cells that are key for the defense against pathogens and cancer. T cells depend on the membrane protein CD45 to initiate T cell receptor signaling, but how CD45 is controlled at the molecular level is poorly understood. read moreA single protein complex balances the very first lineage decision of cells in human: towards foetus or placenta
21 June 2022 The international group of researchers spearheaded by Dick Zijlmans and Hendrik Marks together with colleagues from KU Leuven, examined which proteins are associated with the chromatin and how this affects gene transcription. read moreDutch Society of Clinical Chemistry Science & Innovation Award for the team of Hans Jacobs
14 June 2022 The team of Hans Jacobs pioneers on the development of personalized diagnostics to measure minimal residual disease in patients with multiple myeloma. read moreEuropean grants for groundbreaking Radboudumc research Professors Roshan Cools and Peter Friedl receive ERC Advanced Grant
26 April 2022The European Research Council (ERC) is awarding grants to Roshan Cools and Peter Friedl, both professors at Radboudumc. While Cools will investigate how brains control behaviour in (stressful) situations, Friedl will work on developing a new cancer therapy.
read more